Skip to main content
Log in
Menu
Find a journal
Publish with us
Track your research
Search
Cart
Home
Reactions Weekly
Volumes and issues
Volume 1654, Issue 1
Reactions Weekly
Publishing model
:
Subscription
Back to Overview
Editorial board
Aims and scope
Search all Reactions Weekly articles
Volume 1654, Issue 1
June 2017
June 3, 2017
346 articles in this issue
Gadolinium-based contrast agents safe to use, says US FDA
News item
03 June 2017
Pages: 1 - 1
HSA in Singapore reports local safety signals for 2016
News item
03 June 2017
Pages: 2 - 2
HSA: new recommendations for domperidone use
News item
03 June 2017
Pages: 3 - 3
Ingenol mebutate information updated in Australia
News item
03 June 2017
Pages: 4 - 4
New version of EudraVigilance to be launched
News item
03 June 2017
Pages: 5 - 5
Singapore's HSA analyses AE reports across 2016
News item
03 June 2017
Pages: 6 - 6
Testosterone replacement therapy: risk of ATE/VTE
News item
03 June 2017
Pages: 7 - 7
TGA reinforces interactions warning with Viekira-PAK products
News item
03 June 2017
Pages: 8 - 8
International Society of Pharmacovigilance: new phase
News item
03 June 2017
Pages: 9 - 9
Adverse drug reactions with medicines of unknown identity
Clinical study
03 June 2017
Pages: 10 - 10
Interferon-β: signals of potential adverse events
Clinical study
03 June 2017
Pages: 11 - 11
Metformin: no apparent association with cognition
Clinical study
03 June 2017
Pages: 12 - 12
Acenocoumarol
Case report
03 June 2017
Pages: 13 - 13
Acetazolamide
Case report
03 June 2017
Pages: 14 - 14
Acetylcholine/ergometrine
Case report
03 June 2017
Pages: 15 - 15
Adalimumab
Case report
03 June 2017
Pages: 16 - 16
Adalimumab
Case report
03 June 2017
Pages: 17 - 17
Adalimumab
Case report
03 June 2017
Pages: 18 - 18
Adalimumab/etanercept/infliximab
Case report
03 June 2017
Pages: 19 - 19
Adalimumab/infliximab
Case report
03 June 2017
Pages: 20 - 20
Aflibercept
Case report
03 June 2017
Pages: 21 - 21
Aflibercept/bevacizumab
Case report
03 June 2017
Pages: 22 - 22
Alemtuzumab
Case report
03 June 2017
Pages: 23 - 23
Alendronic acid/zoledronic acid
Case report
03 June 2017
Pages: 24 - 24
Alitretinoin/prednisone
Case report
03 June 2017
Pages: 25 - 25
Alprazolam/hydroxyzine
Case report
03 June 2017
Pages: 26 - 26
Alprazolam/methadone/venlafaxine
Case report
03 June 2017
Pages: 27 - 27
Alteplase
Case report
03 June 2017
Pages: 28 - 28
Alteplase
Case report
03 June 2017
Pages: 29 - 29
Amiodarone
Case report
03 June 2017
Pages: 30 - 30
Amiodarone
Case report
03 June 2017
Pages: 31 - 31
Amiodarone
Case report
03 June 2017
Pages: 32 - 32
Amiodarone
Case report
03 June 2017
Pages: 33 - 33
Amiodarone/thiamazole/mexiletine
Case report
03 June 2017
Pages: 34 - 34
Amiodarone/zolpidem
Case report
03 June 2017
Pages: 35 - 35
Amoxicillin
Case report
03 June 2017
Pages: 36 - 36
Amoxicillin/clavulanic acid
Case report
03 June 2017
Pages: 37 - 37
Amphotericin B
Case report
03 June 2017
Pages: 38 - 38
Amphotericin-b-liposomal/flucytosine/itraconazole
Case report
03 June 2017
Pages: 39 - 39
Antibacterials/aspirin
Case report
03 June 2017
Pages: 40 - 40
Antibacterials/immunosuppressants
Case report
03 June 2017
Pages: 41 - 41
Antihypertensives
Case report
03 June 2017
Pages: 42 - 42
Antineoplastics
Case report
03 June 2017
Pages: 43 - 43
Antineoplastics
Case report
03 June 2017
Pages: 44 - 44
Antineoplastics
Case report
03 June 2017
Pages: 45 - 45
Antiretrovirals
Case report
03 June 2017
Pages: 46 - 46
Antiretrovirals
Case report
03 June 2017
Pages: 47 - 47
Antithymocyte globulin/busulfan/cyclophosphamide
Case report
03 June 2017
Pages: 48 - 48
Antitubercals
Case report
03 June 2017
Pages: 49 - 49
Antituberculars
Case report
03 June 2017
Pages: 50 - 50
1
2
…
7
Next
page
Search
Search by keyword or author
Search
Navigation
Find a journal
Publish with us
Track your research